Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
Holding IRTC?
Track your performance easily
IRTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$55.92 - $124.12
Previous Close$86.48
Volume462.47K
Average Volume (3M)605.75K
Market Cap
$2.78B
Enterprise Value$2.99B
Total Cash (Recent Filing)$522.03M
Total Debt (Recent Filing)$735.36M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Feb 20, 2025EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.85
Shares Outstanding31,298,034
10 Day Avg. Volume729,548
30 Day Avg. Volume605,751
Standard Deviation0.20
R-Squared0.10
Alpha0.00472
Financial Highlights & Ratios
Price to Book (P/B)37.76
Price to Sales (P/S)4.96
Price to Cash Flow (P/CF)28.50
P/FCF Ratio36.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.34
Enterprise Value/Gross Profit9.02
Enterprise Value/Ebitda-27.64
Forecast
1Y Price Target
$99.36Price Target Upside14.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Irhythm Technologies News
Bulls Say, Bears Say
Bulls Say
Market GrowthApp download data for MyZio indicates healthy growth so far in Q4, up +46% versus the same period last year, with a strong exit rate versus Q3 downloads.
Regulatory DevelopmentsThe FDA has cleared two outstanding 510(k)s, paving the way for Zio MCT's future filing and clearance.
Technological AdvancementsIRhythm has contributed to technological advancements in cardiac monitoring, improving diagnosis of arrhythmias and physician workflow.
Bears Say
Financial PerformanceAnalysts have lowered the price target to $96 due to a reduced 2025 sales estimate and slightly lower peer multiples, pointing to a less favorable financial outlook.
Operational And Management IssuesThe transition of the CFO amidst ongoing regulatory challenges could lead to further instability and concern among investors.
Regulatory ChallengesThe delay in the Zio MCT regulatory filing to the third quarter of 2025, along with the potential for another FDA warning letter, introduces significant uncertainty and risk.
---
Ownership Overview
1.62% Insiders
38.84% Mutual Funds
7.42% Other Institutional Investors
36.23% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $55.92 and its highest was $124.11 in the past 12 months.
What is Irhythm Technologies’s market cap?
Currently, no data Available
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Feb 20, 2025 which is in 102 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Oct 30, 2024. The company reported -$1.48 earnings per share for the quarter, missing the consensus estimate of -$0.795 by -$0.685.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -$0.37.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 31,298,035 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$1.48 in its last earnings report, missing expectations of -$0.795. Following the earnings report the stock price went down -4.395%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Among the largest hedge funds holding Irhythm Technologies’s share is Sands Capital Management LLC. It holds Irhythm Technologies’s shares valued at 229M.
---
Irhythm Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$99.36 (14.89% Upside)
$99.36 (14.89% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 198.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $845.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 11.4%
Last 30 Days ▲ 11.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
12.34%
12-Months-Change
Fundamentals
Return on Equity
-103.34%
Trailing 12-Months
Asset Growth
106.86%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
---
IRTC Company Deck
---
IRTC Earnings Call
Q3 2024
0:00 / 0:00
---
IRTC Stock 12 Month Forecast
Average Price Target
$99.36
▲(14.89% Upside)
Technical Analysis
Best Analysts Covering IRTC
1 Year
1 Year Success Rate
6/21 ratings generated profit
1 Year Average Return
-15.35%
reiterated a buy rating 3 months ago
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -15.35% per trade.
---